130 related articles for article (PubMed ID: 15576477)
1. Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
Muris JJ; Cillessen SA; Vos W; van Houdt IS; Kummer JA; van Krieken JH; Jiwa NM; Jansen PM; Kluin-Nelemans HC; Ossenkoppele GJ; Gundy C; Meijer CJ; Oudejans JJ
Blood; 2005 Apr; 105(7):2916-23. PubMed ID: 15576477
[TBL] [Abstract][Full Text] [Related]
2. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
Cillessen SA; Meijer CJ; Ossenkoppele GJ; Castricum KC; Westra AH; Niesten P; Muris JJ; Nijdam HF; van der Hem KG; Flens M; Hooijberg E; Oudejans JJ
Br J Haematol; 2006 Aug; 134(3):283-93. PubMed ID: 16848771
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of caspase 9 and not caspase 8 mediated apoptosis may determine clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
Oudejans JJ; Muris JJ; Meijer CJ
Cell Cycle; 2005 Apr; 4(4):526-8. PubMed ID: 15876872
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells.
Cillessen SA; Reed JC; Welsh K; Pinilla C; Houghten R; Hooijberg E; Deurhof J; Castricum KC; Kortman P; Hess CJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
Blood; 2008 Jan; 111(1):369-75. PubMed ID: 17916749
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma.
ten Berge RL; Meijer CJ; Dukers DF; Kummer JA; Bladergroen BA; Vos W; Hack CE; Ossenkoppele GJ; Oudejans JJ
Blood; 2002 Jun; 99(12):4540-6. PubMed ID: 12036886
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL).
Markovic O; Marisavljevic D; Cemerikic V; Perunicic M; Savic S; Filipovic B; Mihaljevic B
Eur J Haematol; 2011 Mar; 86(3):246-55. PubMed ID: 21198858
[TBL] [Abstract][Full Text] [Related]
7. Taxol induces caspase-10-dependent apoptosis.
Park SJ; Wu CH; Gordon JD; Zhong X; Emami A; Safa AR
J Biol Chem; 2004 Dec; 279(49):51057-67. PubMed ID: 15452117
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
Cillessen SA; Hess CJ; Hooijberg E; Castricum KC; Kortman P; Denkers F; Vos W; van de Wiel MA; Schuurhuis GJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
Clin Cancer Res; 2007 Dec; 13(23):7012-21. PubMed ID: 18056177
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
10. FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis.
Xerri L; Devilard E; Bouabdallah R; Stoppa AM; Hassoun J; Birg F
Br J Haematol; 1999 Sep; 106(3):652-61. PubMed ID: 10468853
[TBL] [Abstract][Full Text] [Related]
11. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
12. c-FLIP does not correlate with response to immunochemotherapy treatment and outcome of patients with nodal diffuse large B-cell lymphoma.
Markovic O; Marisavljevic D; Cemerikic-Martinovic V; Filipovic B; Radovanović S; Zdravković M; Stanisavljevic D; Mihaljevic B
Biomed Pharmacother; 2013 Jun; 67(5):445-9. PubMed ID: 23582793
[TBL] [Abstract][Full Text] [Related]
13. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
14. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.
Engels IH; Stepczynska A; Stroh C; Lauber K; Berg C; Schwenzer R; Wajant H; Jänicke RU; Porter AG; Belka C; Gregor M; Schulze-Osthoff K; Wesselborg S
Oncogene; 2000 Sep; 19(40):4563-73. PubMed ID: 11030145
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
Muris JJ; Meijer CJ; Vos W; van Krieken JH; Jiwa NM; Ossenkoppele GJ; Oudejans JJ
J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling.
Hussain AR; Uddin S; Ahmed M; Bu R; Ahmed SO; Abubaker J; Sultana M; Ajarim D; Al-Dayel F; Bavi PP; Al-Kuraya KS
J Pathol; 2010 Oct; 222(2):180-90. PubMed ID: 20632385
[TBL] [Abstract][Full Text] [Related]
17. Activation of caspase-8 is critical for sensitivity to cytotoxic anti-Fas antibody-induced apoptosis in human ovarian cancer cells.
Hayakawa A; Wu J; Kawamoto Y; Zhou YW; Tanuma S; Nakashima I; Suzuki H
Apoptosis; 2002 Apr; 7(2):107-13. PubMed ID: 11865194
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.
Chawla-Sarkar M; Bae SI; Reu FJ; Jacobs BS; Lindner DJ; Borden EC
Cell Death Differ; 2004 Aug; 11(8):915-23. PubMed ID: 15118763
[TBL] [Abstract][Full Text] [Related]
19. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
Poulaki V; Mitsiades N; Romero ME; Tsokos M
Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
[TBL] [Abstract][Full Text] [Related]
20. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.
Djerbi M; Screpanti V; Catrina AI; Bogen B; Biberfeld P; Grandien A
J Exp Med; 1999 Oct; 190(7):1025-32. PubMed ID: 10510092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
